Bilateral Mammary Artery Graft to Reduce the Chance of Repeat Revascularization

According to previous studies, patients receiving bilateral internal mammary artery conduits during coronary artery bypass grafting have better survival than those receiving a single internal mammary artery. The reason behind this remains unclear, let alone whether there really is lower repeat revascularization rate.

Doble puente mamario para reducir la chance de nuevas revascularizaciones

This analysis compared timing, frequency, and type of repeat coronary revascularization among patients receiving single vs. bilateral internal mammary artery conduits.


Read also: Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?”.


The study included 47,984 consecutive patients undergoing bypass revascularization surgery in 7 centers between 1992 and 2014. 1,482 of these patients received bilateral internal mammary artery conduits.

 

To compare them, patients were propensity matched, which left 1,297 patients in each branch (bilateral vs. single internal mammary artery) for final analyzis. Primary end point was freedom from repeat revascularization.


Read also: Additional Benefit from Radial Artery Graft in Myocardial Revascularization Surgery”.


After a 13.2 year follow up, well matched by age, comorbidities, ventricular function, etc., patients showed that bilateral internal mammary artery conduits are associated with higher freedom from revascularization, compared against single mammary artery conduits (HR= 0.78, CI 95%, 0.65 to 0.94; p=0.009). 19.4% (n=252) of patients in the single mammary artery branch required repeat revascularization at follow up vs. 15.1% (n=196) of patients with bilateral mammary artery conduits (p=0.004).

 

The vast majority of revascularization procedures were PCIs for both groups, the most frequently intervened being the right coronary and the circumflex.

 

In addition, bilateral internal mammary artery conduits were associated with a reduction in all-cause mortality at 12 years (HR, 0.79; p=0.001) and there was no increase in inhospital mortality rate.

 

Conclusion

Bilateral mammary artery conduits were associated with a reduction in repeat revascularization rate and better survival rate at long term, which is why it should be considered more frequently in myocardial revascularization surgery.

 

Editorial Comment

The NEJM has recently published the 5 year ART trial follow up, which randomized CABG patients to bilateral vs. single internal mammary artery grafts. This study, the largest on this matter, was not able to show differences at 5 years, though outcomes at 10 years remain pending. There was increased morbidity among patients receiving bilateral internal mammary artery grafts (sternal infections and need of sternal reconstruction).

 

Original title: Does Use of Bilateral Internal Mammary Artery Grafting Reduce Long-Term Risk of Repeat Coronary Revascularization? A Multicenter Analysis.

Reference: Alexander Iribarne et al. Circulation. 2017;136:1676–1685.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...